![]() |
市場調查報告書
商品編碼
1518752
日本糖尿病市場報告:2024-2032Japan Diabetes Market Report: 2024-2032 |
2023 年日本糖尿病市場規模達到 54IMARC Group美元。
糖尿病是指人體產生和回應胰島素激素的能力受損的一種慢性疾病。這導致碳水化合物代謝異常和血液中葡萄糖水平升高。在日本,很大一部分人口年齡超過 60 歲,是第 2 型糖尿病較為流行的年齡。此外,由於日本飲食中含有很大一部分精製碳水化合物,如白米和麵條,這使得人們患糖尿病和加重糖尿病的風險更高。
隨著西方美食影響力的增強、工作時間的增加以及國內農業產量的下降,消費者現在開始依賴加工食品和快餐,如漢堡、玉米捲、熱狗和披薩。由於這些食品富含碳水化合物、鈉和防腐劑,其消費量的增加導致該國糖尿病病例增加。導致糖尿病病例增加的其他因素包括肥胖人口的增加和久坐的生活方式。然而,為了最大限度地減少該國糖尿病的盛行率,日本政府正在採取多項措施。例如,它透過全民健保系統向在日本居住一年以上的公民和非公民提供健康保險。
The Japan diabetes market size reached US$ 5.4 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 7.3 Billion by 2032, exhibiting a growth rate (CAGR) of 3.3% during 2024-2032.
Diabetes refers to a chronic disease in which the ability of a human body to produce and respond to insulin hormone becomes impaired. This results in abnormal metabolism of carbohydrates and elevated levels of glucose in the blood. In Japan, a large section of the population is over 60 years, an age when type-2 diabetes becomes more prevalent. Moreover, as the Japanese diet consists of a significant portion of refined carbohydrates, like white rice and noodles, it puts the population at a higher risk of developing and aggravating diabetes.
With the growing influence of western cuisines, increasing working hours and declining domestic agricultural production, consumers are now relying on processed food products and fast-food like burger, taco, hotdog and pizza. As these food products are high in carbohydrates, sodium and preservatives, their rising consumption has increased the cases of diabetes in the country. The other factors that are contributing to the increasing cases of diabetes include growing obese population and sedentary lifestyles. However, to minimize the prevalence of diabetes in the country, the Government of Japan is undertaking several initiatives. For instance, it is offering health insurance to both the citizens and non-citizens residing for more than a year in Japan through their universal health care system.
IMARC Group provides an analysis of the key trends in each segment of the Japan diabetes market report, along with forecasts for the period 2024-2032. Our report has categorized the market based on segment.
Oral Antidiabetics
Insulin
Currently, insulin represents the dominant segment, accounting for the majority of the total market share. Insulin in Japan is usually taken through pens, pumps, syringes and jet injectors as they offer convenience to the patients. Increasing diagnostic rates and awareness among patients are enabling them to incorporate insulin therapy for treating diabetes.
The competitive landscape of the market has been analyzed in the report with detailed profiles of key players operative in the industry.